There are 2934 resources available
2550 - FIGHT-202: a phase 2 study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA)
Presenter: Arndt Vogel
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Gastrointestinal tumours, non-colorectal - Invited Discussant 671O and LBA40
Presenter: Per Pfeiffer
Session: Proffered Paper 1 – Gastrointestinal tumours, non-colorectal
Resources:
Slides
Webcast
Proffered Paper – Genitourinary tumours, prostate - Invited Discussant 843O and 844O
Presenter: Karim Fizazi
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Slides
Webcast
5191 - Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): First Results from the RADICALS RT Randomised Controlled Trial (RCT) [NCT00541047]
Presenter: Chris Parker
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
2508 - Adjuvant or salvage radiotherapy for the treatment of localised prostate cancer? A prospectively planned aggregate data meta-analysis
Presenter: Claire Vale
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Abstract
Slides
Webcast
Proffered Paper – Genitourinary tumours, prostate - Invited Discussant LBA48_PR and LBA49_PR
Presenter: Gert De Meerleer
Session: Proffered Paper – Genitourinary tumours, prostate
Resources:
Slides
Webcast
Introduction
Presenter: Dirk De Ruysscher
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Nutrition before and during CCRT, including treatment and prevention of anorexia
Presenter: Jann Arends
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Prevention and management of “in-field” toxicities: Oesophagus, nausea and vomiting, lung, skin, heart
Presenter: Fiona McDonald
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast
Prevention and treatment of fatigue
Presenter: Florian Strasser
Session: ESMO-ESTRO Collaborative session: RTCT in stage III NSCLC: Prevention and management of toxicity including the use of immunotherapy
Resources:
Slides
Webcast